Watch Demo

Australia Antidiabetics Industry Outlook 2024 - 2028

See how Australia Antidiabetics performed compared to key markets such as Canada and Italy.

Key Market Indicators

**Australian Diabetes Medicine Sales to Hit $1.2 Billion by 2028** Australia's diabetes medicine market is anticipated to surge to approximately $1.2 billion by 2028, up from $930 million in 2023. This growth represents a compound annual growth rate (CAGR) of 3.1%. The market has shown a notable increase since 1995, with a year-on-year growth rate of 10.8%. In 2023, Australia ranked third in the global market, with Italy surpassing it at the same $930 million mark. The top three positions in this ranking were held by Italy, Australia, and Croatia, respectively. **Australia's Insulin Exports to Reach $5.7 Million by 2028** Australia's insulin export market is projected to reach $5.7 million by 2028, up from $4.8 million in 2023. This marks an average annual growth rate of 2.3%. The country's insulin supply has increased modestly by 0.6% year-on-year since 1993. In 2023, Australia was ranked 21st in the global market, with Slovakia overtaking it at $4.8 million. The leading countries in this sector were France, Italy, and China, occupying the second, third, and fourth positions, respectively. **Australian Insulin Imports to Climb to $144 Million by 2028** The import market for insulin in Australia is expected to rise to $144 million by 2028, up from $134 million in 2023, growing at an annual rate of 1%. Since 1993, Australian demand for insulin has increased by 2.2% year-on-year. This steady growth highlights the increasing reliance on imported insulin to meet the country's health needs.

Marketing Banner

Australia Antidiabetics Market Data and Forecasts

How much will Australia Antidiabetics Market grow to 2028?

Forecast: Insulin in Dosage Market Size Value in Australia
Forecast: Import of Insulin in Dosage Forms to Australia
Forecast: Export of Insulin in Dosage Forms from Australia
Forecast: Import of Insulin in Dosage Forms to Australia
Forecast: Export of Insulin in Dosage Forms from Australia
More in Antidiabetics Industry for 2028